These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 34316384)

  • 1. Advances in treatment and prevention of hepatitis B.
    Shah NJ; Aloysius MM; Sharma NR; Pallav K
    World J Gastrointest Pharmacol Ther; 2021 Jul; 12(4):56-78. PubMed ID: 34316384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current treatment of chronic hepatitis B: Clinical aspects and future directions.
    Zhu M; Wang H; Lou T; Xiong P; Zhang J; Li L; Sun Y; Wu Y
    Front Microbiol; 2022; 13():975584. PubMed ID: 36160238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions.
    Ahn SH; Chan HL; Chen PJ; Cheng J; Goenka MK; Hou J; Lim SG; Omata M; Piratvisuth T; Xie Q; Yim HJ; Yuen MF;
    Hepatol Int; 2010 Feb; 4(1):386-95. PubMed ID: 20305758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B: Who to treat? A critical review of international guidelines.
    Huang DQ; Lim SG
    Liver Int; 2020 Feb; 40 Suppl 1():5-14. PubMed ID: 32077616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic hepatitis B: case selection and duration of therapy.
    Leung N
    J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selecting appropriate management strategies for chronic hepatitis B: who to treat.
    McMahon BJ
    Am J Gastroenterol; 2006; 101 Suppl 1():S7-12. PubMed ID: 16448451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hepatitis B: our practice and how it relates to the guidelines.
    Yapali S; Talaat N; Lok AS
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):16-26. PubMed ID: 23660419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B vaccination and prevention of hepatocellular carcinoma.
    Kao JH
    Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):907-17. PubMed ID: 26651252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reimbursement policies in the Asia-Pacific for chronic hepatitis B.
    Lim SG; Amarapurkar DN; Chan HL; Crawford DH; Gane EJ; Han KH; Ahn SH; Jafri W; Jia J; Kao JH; Lesmana LA; Lesmana CR; Mohamed R; Phiet PH; Piratvisuth T; Sarin SK; Sollarno JD; Eguchi Y; Mahtab MA; Lee KH
    Hepatol Int; 2015 Jan; 9(1):43-51. PubMed ID: 25788378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel approaches to new therapies for hepatitis B virus infection.
    Loomba R; Liang TJ
    Antivir Ther; 2006; 11(1):1-15. PubMed ID: 16518955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case of Acute-on-Chronic Liver Failure (ACLF) Due to An Uncommon Acute And Chronic Event.
    Agrawal S; Rana BS; Mitra S; Duseja A; Das A; Dhiman RK; Chawla Y
    J Clin Exp Hepatol; 2018 Mar; 8(1):95-97. PubMed ID: 29743800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of guidelines for diagnosis of hepatocellular carcinoma using gadoxetic acid-enhanced MRI in transplantation candidates.
    Jeon SK; Lee JM; Joo I; Yoo J; Park JY
    Eur Radiol; 2020 Sep; 30(9):4762-4771. PubMed ID: 32333148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reasons to consider early treatment in chronic hepatitis B patients.
    Koffas A; Petersen J; Kennedy PT
    Antiviral Res; 2020 May; 177():104783. PubMed ID: 32217150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues.
    Rapti I; Hadziyannis S
    World J Hepatol; 2015 May; 7(8):1064-73. PubMed ID: 26052395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis B: who should be treated?].
    Bradarić N; Kuzmicić N; Bradarić I
    Acta Med Croatica; 2013 Oct; 67(4):311-8. PubMed ID: 24984330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
    ;
    J Hepatol; 2017 Aug; 67(2):370-398. PubMed ID: 28427875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. China's efforts to shed its title of "Leader in liver disease".
    Li X; Xu WF
    Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential characteristics and prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure defined by European Association for the Study of the Liver - Chronic Liver Failure criteria.
    Wu J; Li YY; Hu JH; Jia L; Shi M; Meng FP; Li J; Zhao J; Wang FS; Meng QH
    Hepatol Res; 2018 Feb; 48(2):153-164. PubMed ID: 28456135
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.